Ida Grundberg
Technik-/Wissenschafts-/F&E-Leiter bei OLINK HOLDING AB
Profil
Ida Grundberg is currently the Chief Scientific Officer at Olink Holding AB since 2019.
Prior to this, she worked at Olink Proteomics AB from 2011 to 2019 as the Head of Business Development, VP of Sales & Marketing.
She obtained a doctorate degree from the University of Uppsala and completed her undergraduate and graduate studies at Umea Universitet.
Aktive Positionen von Ida Grundberg
| Unternehmen | Position | Beginn |
|---|---|---|
| OLINK HOLDING AB | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2019 |
Ehemalige bekannte Positionen von Ida Grundberg
| Unternehmen | Position | Ende |
|---|---|---|
Olink Proteomics AB
 Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | Vertrieb & Marketing | 01.09.2019 |
Ausbildung von Ida Grundberg
| Umea Universitet | Graduate Degree |
| University of Uppsala | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OLINK HOLDING AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | Commercial Services |
